Three or More Breast Cancer Foci Increase Specific Mortality Risk

Breast cancer remains a leading cause of oncology-related mortality globally, necessitating precise risk stratification to optimize surgical and systemic interventions [1]. While traditional staging focuses on the size of the primary lesion and nodal involvement, the clinical significance of multifocality, defined as the presence of multiple synchronous tumor foci within the same breast, remains a subject of debate [2]. Current management strategies have evolved from mandatory mastectomy to include breast-conserving therapy for multifocal disease, provided that negative margins can be achieved [3, 4]. However, meta-analyses have produced conflicting data regarding whether these patients face a higher risk of systemic recurrence or breast cancer-specific death compared to those with unifocal tumors [5, 6]. A new national cohort study now provides evidence on how the number of invasive foci influences long-term survival outcomes.